TAS-301 Blocks Receptor-Operated Calcium Influx and Inhibits Rat Vascular Smooth Muscle Cell Proliferation Induced by Basic Fibroblast Growth Factor and Platelet-Derived Growth Factor
スポンサーリンク
概要
- 論文の詳細を見る
The purpose of this study was to determine the effect of a recently synthesized durg, TAS-301 [3-bis(4-methoxyphenyl)methylene-2-indolinone], on vascular smooth muscle cell (VSMC) proliferation and the intracellular signal transduction pathways involved in VSMC proliferation. In an in vitro assay, TAS-301 inhibited the proliferation of rat VSMCs stimulated by platelet-derived growth factor (PDGF)-BB, basic fibroblast growth factor, or 2% fetal bovine serum in a concentration-dependent manner. TAS-301 dosedependently inhibited the PDGF-induced Ca2+ influx; the concentration for the inhibition of Ca2+ influx was nearly identical to that for inhibition of VSMC proliferation. The Ca2+ influx induced by PDGF was also attenuated by NiCl2 but not by nifedipine, suggesting that PDGF-induced Ca2+ influx would be mediated by some non-voltage-dependent mechanisms. Furthermore, TAS-301 inhibited PDGF-induced activation of protein kinase C (PKC) and the phorbol 12-myristate 13-acetate-mediated induction of activator protein 1 (AP-1) in a concentration-dependent manner. These findings indicate that TAS-301 inhibited the proliferation of VSMCs by blocking voltage-independent Ca2+ influx and downstream signals such as the Ca2+/PKC signaling pathway, leading to AP-1 induction.
- 社団法人 日本薬理学会の論文
- 2000-11-01
著者
-
Matsuura Naosuke
Pharmacology Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Nozawa Yoshihisa
Pharmacobioregulation Research Laboratory Hanno Research Center
-
Nozawa Yoshihisa
大鵬薬品工業薬理研究所
-
Nozawa Yoshihisa
Pharmacology Research Laboratory Tokushima Research Center Taiho Pharmaceutical Co. Ltd.
-
KANDA Atsuhiro
Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd.
-
Miyake Hidekazu
Department Of Pharmacology Taiho Pharmaceutical Co. Ltd.
-
Miyake Hidekazu
Cardiovascular Science Research Laboratory Hanno Research Center Taiho Pharmaceutical Co. Ltd.
-
SASAKI Eiji
Pharmacology Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd.
-
MIYOSHI Kazuhisa
Pharmacology Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd.
-
YAMASAKI Yasundo
Cardiovascular Science Research Laboratory, Hanno Research Center, Taiho Pharmaceutical Co., Ltd.
-
Matsuura Naosuke
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Sasaki Eiji
Pharmacology Research Laboratory Tokushima Research Center Taiho Pharmaceutical Co. Ltd.
-
Kanda Atsuhiro
Pharmacobioregulation Research Laboratory Taiho Pharmaceutical Co. Ltd.
-
Miyoshi Kazuhisa
Pharmacology Research Laboratory Tokushima Research Center Taiho Pharmaceutical Co. Ltd.
-
Yamasaki Yasundo
Cardiovascular Science Research Laboratory Hanno Research Center Taiho Pharmaceutical Co. Ltd.
関連論文
- Isolation and cDNA cloning of oxytocin/vasopressin superfamily peptides of Octopus vulgaris(Endocrinology)(Proceeding of the Seventy-Third Annual Meeting of the Zoological Society of Japan)
- IS005 Vascular Smooth Muscle Cell(VSMC)-Specific Overexpression of Angiotensin type2(AT2)Receptor Causes Endothelium-dependent Vasodilation via bradykinin/NO/cGMP pathway
- IS104 Cell-specific Distribution of Angiotensin II Receptor Subtypes and Receptors-mediated Biochemical Changes in Failing Human Hearts
- IS040 Angiotensin Type 2 (AT2) Receptor Inhibits AT1-mediated Intracelluar Alkalosis to Enhance Kinik Production in Vascular Smooth Muscle Cells From Vascular-targeted AT2 Transgenic Mice
- IS070 Angiotensin Type 2 Receptors Are Re-expressed by Cardiac Fibroblasts from Failing Myopathic Hamster Hearts and Inhibit Cell Growth and Fibrillar Collagen Metabolism
- IS050 Cardiac-Specific Overexpression of Angiotensin AT2 receptor Causes Attenuated Response to AT1 receptor - Mediated Chronotropic Action
- Enhancement of Ischemia-Induced Angiogenesis by eNOS Overexpression
- Augmented Angiogenesis in Ischemic Limbs in Transgenic Mice Overexpressing eNOS in Endothelium
- Systemic Delivery of Bone Marrow Mononuclear Cells(BM-MNC) Accelerates Reendothelialization and Markedly Attenuates Intimal Hyperplasia in Balloon-Injured Carotid Artery
- Effects of MET-88,a γ-Butyrobetaine Hydroxylase Inhibitor, on Tissue Carnitine and Lipid Levels in Rats
- GTS-21, a Nicotinic Agonist, Attenuates Multiple Infarctions and Cognitive Deficit Caused by Permanent Occlusion of Bilateral Common Carotid Arteries in Rats
- Chronic Cerebral Hypoperfusion-Induced Neuropathological Changes in Rats
- QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
- QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
- Effects of Antimuscarinic Drugs on Both Urinary Frequency and Cognitive Impairment in Conscious, Nonrestrained Rats
- Protein Kinase C Activation by Helicobacter pylori in Human Gastric Epithelial Cells Limits Interleukin-8 Production Through Suppression of Extracellular Signal-Regulated Kinase
- TAS-301 Blocks Receptor-Operated Calcium Influx and Inhibits Rat Vascular Smooth Muscle Cell Proliferation Induced by Basic Fibroblast Growth Factor and Platelet-Derived Growth Factor
- A Comparative Study on the Effects of Nicotine and GTS : 21, a New Nicotinic Agonist, on the Locomotor Activity and Brain Monoamine Level
- Protective Effect of GTS-21, a Novel Nicotinic Receptor Agonist, on Delayed Neuronal Death Induced by Ischemia in Gerbils
- GTS-21, a Nicotinic Agonist, Protects against Neocortical Neuronal Cell Loss Induced by the Nucleus Basalis Magnocellularis Lesion in Rats